Các bài viết có thể truy cập công khai - Dr. Mrinal PatnaikTìm hiểu thêm
Không có ở bất kỳ nơi nào: 15
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study …
G Coltro, AA Mangaonkar, TL Lasho, CM Finke, P Pophali, R Carr, ...
Leukemia 34 (5), 1407-1421, 2020
Các cơ quan ủy nhiệm: Cancer Research UK, AIRC Foundation for Cancer Research in Italy
Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia
MF Zahid, D Barraco, TL Lasho, C Finke, RP Ketterling, N Gangat, ...
Leukemia & lymphoma 58 (6), 1488-1493, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt …
AA Mangaonkar, DM Swoboda, G Coltro, TL Lasho, PJ Novotny, ...
Leukemia 34 (2), 656-661, 2020
Các cơ quan ủy nhiệm: US National Institutes of Health
Hepatic manifestations of telomere biology disorders
MM Patnaik, PS Kamath, DA Simonetto
Journal of hepatology 69 (3), 736-743, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
MM Patnaik, R Vallapureddy, TL Lasho, KP Hoversten, CM Finke, ...
Leukemia 32 (8), 1850-1856, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts
AA Mangaonkar, N Gangat, A Al-Kali, MA Elliott, KH Begna, CA Hanson, ...
Leukemia research 71, 60-62, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia
JN Barreto, MW Cullen, KC Mara, ME Grove, AG Sierzchulski, NJ Dahl, ...
Leukemia & Lymphoma 60 (14), 3512-3520, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Midostaurin for the treatment of acute myeloid leukemia
MM Patnaik
Future Oncology 13 (21), 1853-1871, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
FGFR1 rearranged hematological neoplasms – molecularly defined and clinically heterogeneous
MM Patnaik, RP Ketterling, A Tefferi
Leukemia & Lymphoma 59 (7), 1520-1522, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable: sorting through the unsorted
AA Mangaonkar, DM Swoboda, TL Lasho, C Finke, RP Ketterling, ...
Leukemia 35 (11), 3329-3333, 2021
Các cơ quan ủy nhiệm: US National Institutes of Health
Making sense of prognostic models in chronic myelomonocytic leukemia
A Nazha, MM Patnaik
Current Hematologic Malignancy Reports 13, 341-347, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Blast-phase chronic myelomonocytic leukemia: more than just semantics
MM Patnaik, A Tefferi, G Garcia-Manero
Leukemia 32 (9), 2093-2094, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia
YH Wang, CY Yao, CC Lin, K Gurashi, FMR Amaral, H Bossenbroek, ...
British journal of haematology 201 (2), 302-307, 2023
Các cơ quan ủy nhiệm: Cancer Research UK
Over 20% of patients report excessive alcohol use pre-transplant
JL Kirsch, W Hogan, M Patnaik, SL Ehlers
Bone Marrow Transplantation 58 (5), 581-583, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
CORRESPONDENCE Open Access
MM Patnaik, T Lasho, M Howard, C Finke, RL Ketterling, A Al-Kali, ...
Các cơ quan ủy nhiệm: US National Institutes of Health
Có tại một số nơi: 134
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
RM Sterner, R Sakemura, MJ Cox, N Yang, RH Khadka, CL Forsman, ...
Blood, The Journal of the American Society of Hematology 133 (7), 697-709, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
A Tefferi, KH Lim, O Abdel-Wahab, TL Lasho, J Patel, MM Patnaik, ...
Leukemia 23 (7), 1343-1345, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Prospective, randomized, double-blind, phase III clinical trial of anti–T-lymphocyte globulin to assess impact on chronic graft-versus-host disease–free survival in patients …
RJ Soiffer, HT Kim, J McGuirk, ME Horwitz, L Johnston, MM Patnaik, ...
Journal of Clinical Oncology 35 (36), 4003-4011, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Inverse association of telomere length with liver disease and mortality in the US population
P Rattan, DD Penrice, JC Ahn, A Ferrer, M Patnaik, VH Shah, PS Kamath, ...
Hepatology communications 6 (2), 399-410, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease
G Goyal, A Ravindran, JR Young, MV Shah, NN Bennani, MM Patnaik, ...
Haematologica 105 (2), 348, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ